Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors

The bovine leukemia virus (BLV) and the human T-lymphothropic viruses (HTLVs) are members of the deltaretrovirus genus of <i>Retroviridae</i> family. An essential event of the retroviral life cycle is the processing of the polyproteins by the viral protease (PR); consequently, these enzy...

Full description

Bibliographic Details
Main Authors: János András Mótyán, Norbert Kassay, Krisztina Matúz, József Tőzsér
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/9/1888
_version_ 1797481407812993024
author János András Mótyán
Norbert Kassay
Krisztina Matúz
József Tőzsér
author_facet János András Mótyán
Norbert Kassay
Krisztina Matúz
József Tőzsér
author_sort János András Mótyán
collection DOAJ
description The bovine leukemia virus (BLV) and the human T-lymphothropic viruses (HTLVs) are members of the deltaretrovirus genus of <i>Retroviridae</i> family. An essential event of the retroviral life cycle is the processing of the polyproteins by the viral protease (PR); consequently, these enzymes became important therapeutic targets of the anti-retroviral drugs. As compared to human immunodeficiency viruses (HIVs), the deltaretroviruses have a different replication strategy, as they replicate predominantly in the DNA form, by forcing the infected cell to divide, unlike HIV-1, which replicates mainly by producing a vast number of progeny virions and by reinfection. Due to bypassing the error-prone reverse transcription step of replication, the PRs of deltaretroviruses did not undergo such extensive evolution as HIV PRs and remained more highly conserved. In this work, we studied the abilities of wild-type and modified BLV, HTLV (type 1, 2 and 3), and HIV-1 PRs (fused to an N-terminal MBP tag) for self-processing. We designed a cleavage site mutant MBP-fused BLV PR precursor as well, this recombinant enzyme was unable for self-proteolysis, the MBP fusion tag decreased its catalytic efficiency but showed an unusually low K<sub>i</sub> for the IB-268 protease inhibitor. Our results show that the HTLV and BLV deltaretrovirus PRs exhibit lower mutation tolerance as compared to HIV-1 PR, and are less likely to retain their activity upon point mutations at various positions, indicating a higher flexibility of HIV-1 PR in tolerating mutations under selective pressure.
first_indexed 2024-03-09T22:14:08Z
format Article
id doaj.art-3ca13decee4f49d1b9be6172f299dfb2
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T22:14:08Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-3ca13decee4f49d1b9be6172f299dfb22023-11-23T19:25:49ZengMDPI AGViruses1999-49152022-08-01149188810.3390/v14091888Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease PrecursorsJános András Mótyán0Norbert Kassay1Krisztina Matúz2József Tőzsér3Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, HungaryDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, HungaryDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, HungaryDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, HungaryThe bovine leukemia virus (BLV) and the human T-lymphothropic viruses (HTLVs) are members of the deltaretrovirus genus of <i>Retroviridae</i> family. An essential event of the retroviral life cycle is the processing of the polyproteins by the viral protease (PR); consequently, these enzymes became important therapeutic targets of the anti-retroviral drugs. As compared to human immunodeficiency viruses (HIVs), the deltaretroviruses have a different replication strategy, as they replicate predominantly in the DNA form, by forcing the infected cell to divide, unlike HIV-1, which replicates mainly by producing a vast number of progeny virions and by reinfection. Due to bypassing the error-prone reverse transcription step of replication, the PRs of deltaretroviruses did not undergo such extensive evolution as HIV PRs and remained more highly conserved. In this work, we studied the abilities of wild-type and modified BLV, HTLV (type 1, 2 and 3), and HIV-1 PRs (fused to an N-terminal MBP tag) for self-processing. We designed a cleavage site mutant MBP-fused BLV PR precursor as well, this recombinant enzyme was unable for self-proteolysis, the MBP fusion tag decreased its catalytic efficiency but showed an unusually low K<sub>i</sub> for the IB-268 protease inhibitor. Our results show that the HTLV and BLV deltaretrovirus PRs exhibit lower mutation tolerance as compared to HIV-1 PR, and are less likely to retain their activity upon point mutations at various positions, indicating a higher flexibility of HIV-1 PR in tolerating mutations under selective pressure.https://www.mdpi.com/1999-4915/14/9/1888human T-lymphotropic virusbovine leukemia virushuman immunodeficiency virusHTLVBLVHIV-1
spellingShingle János András Mótyán
Norbert Kassay
Krisztina Matúz
József Tőzsér
Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
Viruses
human T-lymphotropic virus
bovine leukemia virus
human immunodeficiency virus
HTLV
BLV
HIV-1
title Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
title_full Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
title_fullStr Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
title_full_unstemmed Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
title_short Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
title_sort different mutation tolerance of lentiviral hiv 1 and deltaretroviral blv and htlv protease precursors
topic human T-lymphotropic virus
bovine leukemia virus
human immunodeficiency virus
HTLV
BLV
HIV-1
url https://www.mdpi.com/1999-4915/14/9/1888
work_keys_str_mv AT janosandrasmotyan differentmutationtoleranceoflentiviralhiv1anddeltaretroviralblvandhtlvproteaseprecursors
AT norbertkassay differentmutationtoleranceoflentiviralhiv1anddeltaretroviralblvandhtlvproteaseprecursors
AT krisztinamatuz differentmutationtoleranceoflentiviralhiv1anddeltaretroviralblvandhtlvproteaseprecursors
AT jozseftozser differentmutationtoleranceoflentiviralhiv1anddeltaretroviralblvandhtlvproteaseprecursors